DNDN

Dendreon Corporation News Headlines

$2.68
*  
0.02
 negative 
0.75%
Get DNDN Alerts
*Delayed - data as of Apr. 22, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    DNDN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dendreon's Provenge: What Are Patients And Doctors Saying?
9/8/2011 12:22:00 PM - Seeking Alpha

Dendreon To Announce Restructuring, Volatility Ahead?
9/8/2011 4:36:00 AM - Seeking Alpha

Healthcare Stocks To Watch This Week
9/7/2011 11:23:00 AM - Seeking Alpha

SAC Capital's Top Stock Picks
9/6/2011 11:49:00 PM - Seeking Alpha

Strategy For A Recessionary Portfolio
9/6/2011 11:43:00 AM - Seeking Alpha

Broad Market Sell-off May Have Left ImmunoCellular Therapeutics Selling At Discount
9/6/2011 10:13:00 AM - Seeking Alpha

Top 10 Biotech Stocks Loved By Hedge Funds
9/2/2011 8:55:00 AM - Seeking Alpha

5 Healthcare Stocks To Consider
9/1/2011 8:19:00 AM - Seeking Alpha

Biopharma: The Waiting Is The Hardest Part
8/31/2011 3:27:00 PM - Seeking Alpha

RegMed Daily Dialogue 8/29/11: Post Excessive Sell-Off, September Is Still In The Wind
8/30/2011 11:30:00 AM - Seeking Alpha

Dendreon's Golden Age Is Still On Track
8/29/2011 1:36:00 PM - Seeking Alpha

Dendreon: The Challenge Of Misinformation
8/29/2011 12:59:00 AM - Seeking Alpha

Add Questcor To Your Diversified High-Growth Biotech Portfolio
8/28/2011 6:19:00 AM - Seeking Alpha

6 Health Care Stocks Primed For A Rebound
8/26/2011 1:16:00 AM - Seeking Alpha

After FDA Approval: Will Seattle Genetics Meet the Same Fate as Dendreon?
8/23/2011 6:27:25 PM - Kapitall

Stocks To Watch This Week
8/23/2011 7:58:00 AM - Seeking Alpha

10 Heavily Sold Stocks With Poor Top Line Growth And Weak Profitability
8/23/2011 2:15:00 AM - Seeking Alpha

Dendreon: Assessing Provenge's Effectiveness In Light Of Roche's Zelboraf Approval
8/22/2011 5:07:00 AM - Seeking Alpha

George Soros's Top 30 Stock Picks
8/19/2011 5:49:00 AM - Seeking Alpha

2 Speculative Buys to Consider
8/18/2011 10:28:00 AM - Seeking Alpha

Navigating Cancer Vaccines' High-Risk/High-Reward Field
8/17/2011 11:37:00 AM - Seeking Alpha

5 Stocks That Showed Relative Strength in a Weak Market
8/17/2011 9:41:00 AM - Seeking Alpha

Biotechs Offer Great News, So What's Confusing Investors?
8/16/2011 5:42:00 AM - Seeking Alpha

Healthcare Sector: Top Buy and Sell Ideas Based on Big Movers From Last Week
8/15/2011 4:38:00 PM - Seeking Alpha

Dendreon and Provenge: Too High of a Risk for the Reward
8/15/2011 3:36:00 PM - Seeking Alpha